News
GSK et al file appeal to Delaware Zantac order
GSK and other drugmakers have lost no time in filing an appeal to a …
19724 items found
News
EU orders bird flu vaccine supplies from CSL Seqirus
CSL Seqirus has agreed to provide 665,000 doses of a bird flu vaccine …
R&D
Purity, potency, and safety – affordably – in stem cell therapy
In a new episode of the pharmaphorum podcast, web editor Nicole …
R&D
Don’t sweat an FDA sIRB mandate in clinical research – It’s good news for everyone
We knew it was coming, and now it’s close. By the end of 2024, the US …
News
UK pharma industry delivers election ‘wish list’
The Association of the British Pharmaceutical Industry (ABPI) is …
News
ALZpath licenses Alzheimer’s diagnosis tech to Roche
Diagnostics giant Roche is putting its weight behind a biomarker for …
News
FDA clears Ipsen’s primary biliary cholangitis drug
Ipsen has been given accelerated approval by the FDA for Iqirvo, …
Patients
FDA wants to make the home a healthcare hub
During the pandemic, the world became accustomed to carrying out more …
R&D
Sponsored
12 Questions with Dr Jay Shah
Dr Jay Shah is Chief Medical Officer of Aktiia. Dr Shah completed his …
News
Lilly’s Alzheimer’s drug set to join Leqembi after FDA vote
An FDA advisory committee has delivered a strong endorsement to Eli …
News
Moderna says COVID/flu shot clears phase 3 hurdle
Moderna says it has become the first company in the pharma sector …
News
Scotland first UK nation to clear Mounjaro use for obesity
Scotland has become the first country in the UK to back NHS use of …
Patients
Gilead's HIV success and controversy: Expanding access amid ...
Gilead has grown to become a leader in the fight against HIV and has announced efforts to improve access to a new, highly effective medicine.
Sales & Marketing
Enabling site success: Key insights to reducing burden and i...
Investigator sites are essential for successful execution of clinical trials – ensuring studies are conducted ethically, safely, and in compliance with regulatory standards.
Sales & Marketing
Deep Dive: Commercialisation 2024
In this issue, we unpack Ozempic’s rise to superstar status and the risks associated with its off-label use.
Digital
Sponsored
How to deal with fragmented data - A $12.9 million challenge
In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies are sitting on – are an invaluable asset.
Digital
Access to genomic surveillance: Open science and public heal...
The pandemic served as a catalyst for a revolution in genomic surveillance for tracking pathogens.
Sales & Marketing
Sponsored
Launch Excellence: Moments of Truth
The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.
Patients
Partner Content
How walking in a patient's shoes adds value to your patient ...
Imagine the difference it would make if everyone in your organisation had firsthand experience of living with one of the conditions you help treat. What insights would you gain?
R&D
Partner Content
BIO-Europe's 30th Anniversary Landmark Event in Stockholm
BIO-Europe™ celebrates 30 years of facilitating partnerships this Fall. In 1994, BIO-Europe launched with the mission to drive biotech innovation and
